The global parenteral packaging market size is evaluated at USD 35.99 billion in 2025 and is forecasted to hit around USD 60.89 billion by 2034, growing at a CAGR of 6.02% from 2025 to 2034.The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Parenteral Packaging Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Parenteral Packaging Market Revenue and Volume Forecast, by Products
8.1.1. Bottles
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Ampoules
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Vials
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Prefilled Syringes
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Cartridges
8.1.5.1. Market Revenue and Volume Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Volume Forecast
9.1. Parenteral Packaging Market Revenue and Volume Forecast, by Drug
9.1.1. Small Molecules
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Biologics
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Vaccines
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Biosimilars
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Volume Forecast
10.1. Parenteral Packaging Market Revenue and Volume Forecast, by Material
10.1.1. Glass
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Polymer
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. PVC
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Volume Forecast
11.1. Parenteral Packaging Market Revenue and Volume Forecast, by Packaging
11.1.1. Small Volume Parenteral
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Large Volume Parenteral
11.1.2.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Products
12.1.2. Market Revenue and Volume Forecast, by Drug
12.1.3. Market Revenue and Volume Forecast, by Material
12.1.4. Market Revenue and Volume Forecast, by Packaging
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Products
12.1.5.2. Market Revenue and Volume Forecast, by Drug
12.1.5.3. Market Revenue and Volume Forecast, by Material
12.1.5.4. Market Revenue and Volume Forecast, by Packaging
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Products
12.1.6.2. Market Revenue and Volume Forecast, by Drug
12.1.6.3. Market Revenue and Volume Forecast, by Material
12.1.6.4. Market Revenue and Volume Forecast, by Packaging
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Products
12.2.2. Market Revenue and Volume Forecast, by Drug
12.2.3. Market Revenue and Volume Forecast, by Material
12.2.4. Market Revenue and Volume Forecast, by Packaging
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Products
12.2.5.2. Market Revenue and Volume Forecast, by Drug
12.2.5.3. Market Revenue and Volume Forecast, by Material
12.2.5.4. Market Revenue and Volume Forecast, by Packaging
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Products
12.2.6.2. Market Revenue and Volume Forecast, by Drug
12.2.6.3. Market Revenue and Volume Forecast, by Material
12.2.6.4. Market Revenue and Volume Forecast, by Packaging
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Products
12.2.7.2. Market Revenue and Volume Forecast, by Drug
12.2.7.3. Market Revenue and Volume Forecast, by Material
12.2.7.4. Market Revenue and Volume Forecast, by Packaging
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Products
12.2.8.2. Market Revenue and Volume Forecast, by Drug
12.2.8.3. Market Revenue and Volume Forecast, by Material
12.2.8.4. Market Revenue and Volume Forecast, by Packaging
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Products
12.3.2. Market Revenue and Volume Forecast, by Drug
12.3.3. Market Revenue and Volume Forecast, by Material
12.3.4. Market Revenue and Volume Forecast, by Packaging
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Products
12.3.5.2. Market Revenue and Volume Forecast, by Drug
12.3.5.3. Market Revenue and Volume Forecast, by Material
12.3.5.4. Market Revenue and Volume Forecast, by Packaging
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Products
12.3.6.2. Market Revenue and Volume Forecast, by Drug
12.3.6.3. Market Revenue and Volume Forecast, by Material
12.3.6.4. Market Revenue and Volume Forecast, by Packaging
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Products
12.3.7.2. Market Revenue and Volume Forecast, by Drug
12.3.7.3. Market Revenue and Volume Forecast, by Material
12.3.7.4. Market Revenue and Volume Forecast, by Packaging
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Products
12.3.8.2. Market Revenue and Volume Forecast, by Drug
12.3.8.3. Market Revenue and Volume Forecast, by Material
12.3.8.4. Market Revenue and Volume Forecast, by Packaging
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Products
12.4.2. Market Revenue and Volume Forecast, by Drug
12.4.3. Market Revenue and Volume Forecast, by Material
12.4.4. Market Revenue and Volume Forecast, by Packaging
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Products
12.4.5.2. Market Revenue and Volume Forecast, by Drug
12.4.5.3. Market Revenue and Volume Forecast, by Material
12.4.5.4. Market Revenue and Volume Forecast, by Packaging
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Products
12.4.6.2. Market Revenue and Volume Forecast, by Drug
12.4.6.3. Market Revenue and Volume Forecast, by Material
12.4.6.4. Market Revenue and Volume Forecast, by Packaging
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Products
12.4.7.2. Market Revenue and Volume Forecast, by Drug
12.4.7.3. Market Revenue and Volume Forecast, by Material
12.4.7.4. Market Revenue and Volume Forecast, by Packaging
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Products
12.4.8.2. Market Revenue and Volume Forecast, by Drug
12.4.8.3. Market Revenue and Volume Forecast, by Material
12.4.8.4. Market Revenue and Volume Forecast, by Packaging
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Products
12.5.2. Market Revenue and Volume Forecast, by Drug
12.5.3. Market Revenue and Volume Forecast, by Material
12.5.4. Market Revenue and Volume Forecast, by Packaging
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Products
12.5.5.2. Market Revenue and Volume Forecast, by Drug
12.5.5.3. Market Revenue and Volume Forecast, by Material
12.5.5.4. Market Revenue and Volume Forecast, by Packaging
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Products
12.5.6.2. Market Revenue and Volume Forecast, by Drug
12.5.6.3. Market Revenue and Volume Forecast, by Material
12.5.6.4. Market Revenue and Volume Forecast, by Packaging
13.1. Adelphi Healthcare Packaging
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Akorn, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Alcami Corporation, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Ardena Holding NV
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Becton, Dickinson and Company
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Berkshire Sterile Manufacturing
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Baxter International Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Berry Global Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Catalent Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Gerresheimer AG.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample